
Asher Chanan-Khan
Professor of Medicine · Mayo Clinic College of Medicine and Science
Credentials: · · ·
History
- 1998–1999
Department of Medicine New York University School of Medicine
- 1996–1998
Department of Medicine New York University School of Medicine
Department of Medicine New York University School of Medicine

- 1989–1993
Doctor of Medicine
Research
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
New England Journal of Medicine · 2016 · 1,242 citations
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
New England Journal of Medicine · 2007 · 1,038 citations
Blood · 2007 · 625 citations

89 papers

60 papers · 17 as a resident

49 papers

24 papers · 11 as a fellow

23 papers

23 papers

21 papers

20 papers
Grants
- 2019–2024
Therapeutic Implication of CD38 in CLL
National Cancer Institute · R01
Contact PI · $2.4M · Mayo Clinic Jacksonville
- 2000–2003
Vaccine for Patients with Non Hodgkins Lymphoma
National Cancer Institute · R21
Contact PI · $159.9K · Roswell Park Cancer Institute Corp
Clinical trials
- 2018–2026
Principal investigator · Terminated · Phase 2
Mayo Clinic
- 2016–2026
Principal investigator · Completed · Phase 2
Mayo Clinic
- 2015–2018
Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia
Principal investigator · Terminated · Phase 1, Phase 2
Mayo Clinic
- 2010–2011
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia
Principal investigator · Withdrawn · Phase 2
National Cancer Institute (NCI)




